Key points are not available for this paper at this time.
The current guidelines allow for reproducible determination of liver metastasis HGPs. As HGPs impact overall survival after surgery for CRCLM, they may serve as a novel biomarker for individualised therapies.
Dam et al. (Thu,) studied this question.